Found 17 matching trials
Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis PHASE2 Background:
Chronic hepatitis D is a serious liver disease caused by a vir...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Efficacy and Safety Study of PEG-rIL-29 Plus Ribavirin to Treat Chronic Hepatitis C Virus Infection PHASE2 Interleukin 29 (IL-29) is a substance that is produced in the body to help ...
Show More Location
Multiple Locations
Learn More & Join Trial
Pegylated Interferon Lambda for Treatment of COVID-19 Infection PHASE2 A randomized, open-label, 2 arm, pilot trial of Lambda 180 mcg administered...
Show More Learn More & Join Trial
Treatment of Chronic Delta Hepatitis With Lonafarnib, Ritonavir and Lambda Interferon PHASE2 Background:
Infection with hepatitis D virus leads to a chronic liver dise...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C PHASE3 The purpose of this study is to determine if 48 weeks of therapy with Pegyl...
Show More Location
Local Institution
Learn More & Join Trial
Pegylated Interferon Lambda Treatment for COVID-19 PHASE2 Prospective randomized trial to assess the antiviral efficacy of Pegylated ...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Safety and Efficacy Study of Pegylated Interferon Lambda With and Without Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3 PHASE3 The purpose of this study is to determine if 24 weeks of treatment with Peg...
Show More Location
Mayo Clinic Arizona
Learn More & Join Trial
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen PHASE2 At least 1 dose of pegIFNλ will be identified which is safe, well tolerated...
Show More Location
Advanced Clinical Research Institute
Learn More & Join Trial
Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection PHASE1 Interleukin 29 (IL-29) is a substance that is produced in the body to help ...
Show More Location
Northwestern Memorial Hospital
Learn More & Join Trial
Safety and Efficacy Study in Subjects With Chronic HCV and Underlying Hemophilia PHASE3 The primary objective for this study is to evaluate the proportion of subje...
Show More Location
Stanford Boswell Clinic
Learn More & Join Trial